Managing Your Care

643 articles

Research
August 18, 2016 • 2 Min

Exploring the Effectiveness of an Experimental Class of Drug

Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?

Research
August 31, 2016 • 2 Min

A New Chemotherapy and Radiation Regimen to Shrink Tumors Before Surgery

Researchers are testing a new combination of chemotherapies and radiation to shrink pancreatic cancer tumors and make surgical removal possible.

Research
September 14, 2016 • 2 Min

Slowing the Growth of Pancreatic Tumors Before Surgery

A chemoradiation clinical trial tests standard chemotherapy plus an anti-malaria drug and compares two types of radiation treatments, to slow tumor growth.

Research
September 27, 2016 • 2 Min

High-Dose Focused Radiation after Surgical Removal of Pancreatic Tumors

A clinical trial looks at the effectiveness of stereotactic body radiation therapy in killing cancer cells in the margins after pancreatic tumor removal.

Research
October 10, 2016 • 2 Min

A Novel Combination to Slow Pancreas Tumors that Cannot Be Surgically Removed

Can a combination of standard drugs, a PARP inhibitor, and intensity modulated radiation therapy to slow pancreatic tumor growth?

Research
October 31, 2016 • 2 Min

Using a Vitamin to Make Low-Dose Chemotherapy More Effective

A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.

Research
November 11, 2016 • 2 Min

Immunotherapy to Help Shrink Pancreatic Tumors for Surgery

Researchers are looking at adding checkpoint drugs–a type of immunotherapy–to standard chemoradiation to shrink pancreatic cancer for surgery.

Research
November 28, 2016 • 2 Min

Testing the Effectiveness of Radiation and Standard Treatment

A clinical trial compares FOLFIRINOX plus stereotactic body radiation therapy (SBRT) with just FOLFIRINOX for pancreatic cancer that has spread locally.

Research
December 9, 2016 • 2 Min

Muting Chemical Signals to Slow or Stop the Spread of Pancreatic Cancer

A clinical trial tests a drug that turns off chemical signals in the body that promote the growth of tumors and the spread of pancreatic cancer.

Research
December 22, 2016 • 2 Min

A New Approach to Treating Some Advanced Pancreatic Cancer Patients

A clinical trial uses PEGPH20, a synthetic form of a human enzyme, to make treatment more effective in pancreatic cancer patients with high tumor pressure.

Research
January 2, 2017 • 2 Min

Testing Targeted Immunotherapy Against Pancreatic Cancer

Targeted immunotherapy is the focus of a clinical trial that tests the drug ibrutinib, approved for leukemia treatment, against pancreatic cancer.

Research
January 27, 2017 • 2 Min

Electrical Pulses to Destroy Pancreatic Cancer Cells

A clinical trial looks the effectiveness of NanoKnife surgery on pancreatic cancer tumors that cannot be removed by traditional surgery.

Research
February 9, 2017 • 2 Min

Testing Standard Treatment Plus an Antibody to Shrink Pancreatic Tumors

Researchers are testing whether adding a monoclonal antibody to standard chemotherapy will make locally advanced pancreatic cancer qualify for surgery.

Research
March 10, 2017 • 2 Min

Maintenance Chemotherapy for Stable Metastatic Pancreatic Cancer

A clinical trial tests the diabetes drug metformin and transplant rejection preventative rapamycin to act as maintenance chemotherapy for pancreatic cancer.

Research
March 23, 2017 • 2 Min

Two Types of Immunotherapy for Surgically Removable Pancreatic Cancer

A clinical trial compares the effectiveness of two different types of immunotherapy with standard treatment after pancreatic cancer surgery.